Today's Information

Provided by: AmCad BioMed Corporation
SEQ_NO 2 Date of announcement 2022/07/05 Time of announcement 13:49:45
Subject 
 AmCad BioMed Corporation is invited to
Online Investor Conference held by KGI Securities
Date of events 2022/07/19 To which item it meets paragraph 12
Statement 
1.Date of institutional investor conference:2022/07/19
2.Time of institutional investor conference:14:00
3.Location of institutional investor conference:
Online Investor Conference held by KGI Securities
4.Outline of institutional investor conference:
AmCad is committed to assisting medical professionals in making efficient
and accurate diagnosis through the support of detailed sonographic
visualization and quantification.
By integrating AI technology with clinicians' expertise,
AmCad will continue to pioneer best-in-class imaging solutions.
AmCad UT is world's first ultrasound CAD for Thyroid Cancer detection.
AmCad UO is Innovative solution to help physicians evaluate
the risk of OSA in ten minutes. At present,two products successfully
entered health centers such as National Taiwan University Hospital,
Show Chwan Hospital, Changhua Christian Hospital ,Harvard Clinic etc.
The management team continues to expand domestic and foreign
markets actively.
5.Any other matters that need to be specified:
Please find the completed financial information on the investor conference
item of the MOPS.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

AmCad BioMed Corporation published this content on 05 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2022 06:02:07 UTC.